retatrutide triple agonist glp-1 gip glucagon phase 2 results for weight loss: Study shows 30% body weight loss LY3437943, a novel triple glucagon,

Effect of the glucagon-like peptide-1 receptor agonists on autonomic function in subjects with diabetes: a systematic review and meta-analysis

Protein shakes designed for GLP-1 users offer a convenient way to meet protein targets when appetite is limited

JAMA Ophthalmol [Internet]

Yan et al., 2022), but the safety and efficacy of melatonin used as antioxidant therapy for clinical treatment of aging-related diseases still need further exploration (Yan et al., 2022)

Gestational diabetes Treatment

Melanocortin-4 receptor in the medial amygdala regulates emotional stress-induced anxiety-like behavior, anorexia and corticosterone secretion